March 15 Deadline Alert: Law Offices of Howard G. Smith Reminds MannKind Corp. Investors of Upcoming Lead Plaintiff Deadline

BENSALEM, Pa--(BUSINESS WIRE)--

Law Offices of Howard G. Smith reminds investors of the upcoming March 15, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased MannKind Corp. ("MannKind" or the "Company") MNKD securities between August 10, 2015 and January 5, 2016, inclusive (the "Class Period"). Investors who suffered losses on their investment in MannKind securities are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights.

The complaint alleges that throughout the Class Period Defendants issued false and misleading statements and/or failed to disclose that: (1) contrary to Defendants' assurances, the mandated pulmonary testing or spirometry was still a significant issue impeding sales of Afrezza, the Company's rapid-acting insulin; and (2) as a result, Defendants' statements about MannKind's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times.

If you purchased MannKind shares, you may move the Court no later than March 15, 2016 to request appointment as lead plaintiff. To be a member of the class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160314005229/en/